Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain P Chantepie

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood Research|April 12, 2014
Leptomeningeal involvement in CLLSylvain P Chantepie, Edouard Cornet
Blood|November 17, 2010
Hematogones: a new prognostic factor for acute myeloblastic leukemiaSylvain P Chantepie, Véronique Salaün, Jean-Jacques Parienti, et al.
American Journal of Hematology|April 27, 2013
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapySarah Ivanoff, Berengere Gruson, Sylvain P Chantepie, et al.
Trials|November 24, 2015
Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trialSylvain P Chantepie, Jean-Baptiste Mear, Lydia Guittet, et al.
Leukemia & Lymphoma|November 14, 2014
Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemiaSylvain P Chantepie, Emilie Reboursiere, Jean-Baptiste Mear, et al.
Leukemia Research|December 1, 2009
ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemiaSylvain P Chantepie, Dominique Vaur, Christoph Grunau, et al.
American Journal of Hematology|March 3, 2016
The prognostic value of hematogones in patients with acute myeloid leukemiaSylvain P Chantepie, Jean-Jacques Parienti, Véronique Salaun, et al.
Transfusion|November 19, 2016
Blood transfusion in hematologic intensive care unitSylvain P Chantepie, Jean-Baptiste Mear, Jean-Jacques Parienti, et al.
Leukemia & Lymphoma|February 17, 2016
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 casesAnne-Claire Gac, Nabih Azar, Etienne Daguindau, et al.
American Journal of Hematology|February 24, 2018
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centersSylvain P Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood Research|April 12, 2014
Leptomeningeal involvement in CLLSylvain P Chantepie, Edouard Cornet
Blood|November 17, 2010
Hematogones: a new prognostic factor for acute myeloblastic leukemiaSylvain P Chantepie, Véronique Salaün, Jean-Jacques Parienti, et al.
American Journal of Hematology|April 27, 2013
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapySarah Ivanoff, Berengere Gruson, Sylvain P Chantepie, et al.
Trials|November 24, 2015
Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trialSylvain P Chantepie, Jean-Baptiste Mear, Lydia Guittet, et al.
Leukemia & Lymphoma|November 14, 2014
Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemiaSylvain P Chantepie, Emilie Reboursiere, Jean-Baptiste Mear, et al.
Leukemia Research|December 1, 2009
ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemiaSylvain P Chantepie, Dominique Vaur, Christoph Grunau, et al.
American Journal of Hematology|March 3, 2016
The prognostic value of hematogones in patients with acute myeloid leukemiaSylvain P Chantepie, Jean-Jacques Parienti, Véronique Salaun, et al.
Transfusion|November 19, 2016
Blood transfusion in hematologic intensive care unitSylvain P Chantepie, Jean-Baptiste Mear, Jean-Jacques Parienti, et al.
Leukemia & Lymphoma|February 17, 2016
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 casesAnne-Claire Gac, Nabih Azar, Etienne Daguindau, et al.
American Journal of Hematology|February 24, 2018
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centersSylvain P Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, et al.
Pageof 2